Chesley Taft & Associates’s AstraZeneca AZN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$9.25M	Buy	132,435 +525	+0.4%	+$36.7K	0.41%	60
2025 Q1	$9.7M	Buy	131,910 +128,510	+3,780%	+$9.45M	0.47%	59
2024 Q4	$223K	Sell	3,400 -13,125	-79%	-$860K	0.01%	316
2024 Q3	$1.29M	Buy	+16,525	New	+$1.29M	0.06%	177